Bunzl plc has supported Diabetes UK since 2011, investing over £125,000 in a number of research projects:
2018: The cost-effectiveness of DiRECT’s Type 2 remission by Professor Mike Lean
2017: A ‘one stop’ diagnosis for Mody project by Dr Timothy McDonald
2016: Artificial sweeteners: a protective effect on blood vessel injury in the eye and kidney? - Dr Havovi Chichger
2015: Can inulin help prevent Type 2? Dr Nicola Guess
2014: Preventing complications takes AGEs - Dr Yvonne Alexander, Training the brain in Type 2 diabetes - Dr Arie Nouwen
2013: Professor Khunti’s ‘Understanding barriers to the management of Type 2 diabetes’ research project.
2012: Peer group research undertaken at Addenbrookes by Professor David Simmons.
2011: Alterations in plasma microRNAs in patients with Type 2 diabetes, by Dr Manuel Mayr, King’s College London.
“We’re proud to have invested over £125,000 into a number of world-leading research projects. This funding will have helped to further advance the understanding of diabetes and how together we can improve the lives of those living with diabetes.” Julie Welch, Director of Group HR
- Corporate Partners’ products or services, as well as those highlighted on Diabetes UK’s website, are not necessarily endorsed by Diabetes UK.
- Diabetes UK is not responsible for the content of external websites.